Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

16.6K
The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...
16.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability.

Leukemia·2026
Same author

Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate.

bioRxiv : the preprint server for biology·2025
Same author

Upfront menin-inhibitor resistance in multiply pretreated leukemias.

Experimental hematology·2025
Same author

Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy Strategy.

bioRxiv : the preprint server for biology·2025
Same author

Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response.

Leukemia·2025
Same author

CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy.

Journal for immunotherapy of cancer·2025

Related Experiment Video

Updated: Feb 19, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.8K

Flow Cytometry in Pediatric Hematopoietic Malignancies.

Jie Li1, Gerald Wertheim1, Michele Paessler2

  • 1Department of Pathology and Laboratory Medicine, Division of Hematopathology, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Hospital of University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Clinics in Laboratory Medicine
|November 13, 2017
PubMed
Summary

Flow cytometry is crucial for diagnosing pediatric blood cancers, differing from adult evaluations. It aids in distinguishing normal cells from cancerous ones and monitoring treatment effectiveness.

Keywords:
HematogonesLeukemiaLymphoblastsLymphomaPediatric flow cytometry

More Related Videos

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells
10:20

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells

Published on: March 24, 2023

2.2K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.4K

Related Experiment Videos

Last Updated: Feb 19, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.8K
Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells
10:20

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells

Published on: March 24, 2023

2.2K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

12.4K

Area of Science:

  • Hematology
  • Immunophenotyping
  • Pediatric Oncology

Background:

  • Hematopoietic neoplasms require precise diagnostic methods.
  • Pediatric and adult neoplasms exhibit distinct biological and clinical features.
  • Flow cytometry offers valuable insights into cellular populations within hematopoietic tissues.

Purpose of the Study:

  • To review the utility of flow cytometry in evaluating pediatric hematopoietic neoplasms.
  • To highlight key differences in flow cytometry applications between pediatric and adult cases.
  • To discuss specific applications in pediatric hematologic malignancies.

Main Methods:

  • Literature review focusing on flow cytometry applications in pediatric hematologic neoplasms.
  • Analysis of studies comparing pediatric and adult hematopoietic neoplasm evaluations.
  • Discussion of diagnostic challenges and flow cytometry's role in addressing them.

Main Results:

  • Flow cytometry is essential for distinguishing hematogones from B-lymphoblasts in pediatric samples.
  • It enables the detection of minimal residual disease after novel targeted therapies.
  • The technique is vital for the comprehensive evaluation of pediatric myeloid neoplasms.

Conclusions:

  • Flow cytometry is indispensable for the accurate diagnosis and monitoring of pediatric hematopoietic neoplasms.
  • Understanding the nuances between pediatric and adult evaluations is critical for effective clinical application.
  • This method supports personalized treatment strategies and prognostication in young patients.